Description
NORPH
Description
Food supplement of a patented formula (iphytoone) of turmeric-phospholipid.
Ingredients
Turserin phospholipid turmeric (curcumin 95% from rhizomes of Curcuma longa L., sunflower phospholipids), corn starch; bulking agents: mannitol, microcrystalline cellulose, dibasic calcium phosphate; stabilizer: cross-linked sodium carboxymethylcellulose; anti-caking agents: magnesium salts of fatty acids, silicon dioxide.
Gluten free.
Nutritional characteristics
How to use
It is recommended to take 1-2 fast-disintegrating tablets per day at meals with a sip of water.
Warnings
Keep out of reach of children under 3 years.
Do not exceed the recommended daily dose.
Supplements are not intended as a substitute for a varied diet.
Do not use during pregnancy.
In case of alterations of liver function, biliary function or gallstones, the use of the product is not recommended. If you are taking medications, it is advisable to seek the advice of your doctor.
Conservation
Store below 30°C.
Validity with intact packaging: 36 months.
Format
Box of 30 rapidly disintegrating tablets.
Net weight: 28.02 g.
Code 905289930
Bibliography
- Kidd, PM Bioavailability and activity of Phytosome complexes from botanical polyphenolis: the silymarin, curcumin, green tea, and grape seed extracts. Alt. Med. Rev. 2009, 14, 226-246.
- Aggarwal, B.B.; Sung, B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern objectives. Trends Pharmacol. Sci. 2009, 30, 85-94.
- Jurenka, JS Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of precolinical and clinical research. Alternate Med. Rev. 2009, 14, 141-153.
- Anand, P.; Kunnumakkara, A.B.; Newman, R.A.; Aggarwal, B.B. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 2007, 4, 807-818.
- Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP, Gescher AJ., Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine, Cancer Chemother Pharmacol. 2007 Jul;60(2):171-7. Epub 2006 Oct 19.
- Cuomo, J., et al., Comparative Absorption of a Standardized Curcuminoid Mixture and Its Lecithin Formulation. J Nat Prod, 2011.
- Belcaro G., Cesarone MR, Dugall M. et al., Product-evaluation registry of Meriva, a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis, Panminerva Medica 2010 June;52(2 Suppl 1).55-62 .
- Belcaro G., Cesarone MR, Dugall M. et al., Efficacy and Safety of Meriva®, al., Curcumin-phosphatidylcholine Complex, during Extended Administration in Osteoarthritis Patients Altern Med Rev. 2010 Dec;15(4):337- 44.
- Allegri P., Mastromarino A. Management of chronic anterior uveitis relapses: efficacy of the treatment with oral phospholipidic curcumin. Long term follow-up, Clinical Ophthalmology 2010, 4, 1-6
- Steigerwalt, R., et al., Meriva(R), a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. Panminerva Med, 2012. 54(1 Suppl 4): p. 11-6.
- Appendino G. et al., "Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study" Panminerva Medica 2011, 53 (3 Suppl 1):43-90
Food supplement of a patented formula (iphytoone) of turmeric-phospholipid.
Ingredients
Turserin phospholipid turmeric (curcumin 95% from rhizomes of Curcuma longa L., sunflower phospholipids), corn starch; bulking agents: mannitol, microcrystalline cellulose, dibasic calcium phosphate; stabilizer: cross-linked sodium carboxymethylcellulose; anti-caking agents: magnesium salts of fatty acids, silicon dioxide.
Gluten free.
Nutritional characteristics
| Average values | For 1 tablet | For 2 tablets |
| Turmeric-phospholipid of which curcumin |
500 mg 100 mg |
1,000 mg 200 mg |
| Nutritional values | Per 100 g |
| Energy | 329 kcal 1.364 kJ |
| Fats of which saturated of which monounsaturated of which polyunsaturated |
12.64 g 3.65 g 2.15 g 6.84 g |
| Carbohydrates of which sugars of which polyols |
38.96 g 0.62 g 10.28 g |
| Protein (N x 6.25) | 2.04 g |
| Salt (Sodium x 2.5) | 0.39 g |
| Fibers | 33.9 g |
How to use
It is recommended to take 1-2 fast-disintegrating tablets per day at meals with a sip of water.
Warnings
Keep out of reach of children under 3 years.
Do not exceed the recommended daily dose.
Supplements are not intended as a substitute for a varied diet.
Do not use during pregnancy.
In case of alterations of liver function, biliary function or gallstones, the use of the product is not recommended. If you are taking medications, it is advisable to seek the advice of your doctor.
Conservation
Store below 30°C.
Validity with intact packaging: 36 months.
Format
Box of 30 rapidly disintegrating tablets.
Net weight: 28.02 g.
Code 905289930
Bibliography
- Kidd, PM Bioavailability and activity of Phytosome complexes from botanical polyphenolis: the silymarin, curcumin, green tea, and grape seed extracts. Alt. Med. Rev. 2009, 14, 226-246.
- Aggarwal, B.B.; Sung, B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern objectives. Trends Pharmacol. Sci. 2009, 30, 85-94.
- Jurenka, JS Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of precolinical and clinical research. Alternate Med. Rev. 2009, 14, 141-153.
- Anand, P.; Kunnumakkara, A.B.; Newman, R.A.; Aggarwal, B.B. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 2007, 4, 807-818.
- Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP, Gescher AJ., Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine, Cancer Chemother Pharmacol. 2007 Jul;60(2):171-7. Epub 2006 Oct 19.
- Cuomo, J., et al., Comparative Absorption of a Standardized Curcuminoid Mixture and Its Lecithin Formulation. J Nat Prod, 2011.
- Belcaro G., Cesarone MR, Dugall M. et al., Product-evaluation registry of Meriva, a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis, Panminerva Medica 2010 June;52(2 Suppl 1).55-62 .
- Belcaro G., Cesarone MR, Dugall M. et al., Efficacy and Safety of Meriva®, al., Curcumin-phosphatidylcholine Complex, during Extended Administration in Osteoarthritis Patients Altern Med Rev. 2010 Dec;15(4):337- 44.
- Allegri P., Mastromarino A. Management of chronic anterior uveitis relapses: efficacy of the treatment with oral phospholipidic curcumin. Long term follow-up, Clinical Ophthalmology 2010, 4, 1-6
- Steigerwalt, R., et al., Meriva(R), a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. Panminerva Med, 2012. 54(1 Suppl 4): p. 11-6.
- Appendino G. et al., "Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study" Panminerva Medica 2011, 53 (3 Suppl 1):43-90
